Spots Global Cancer Trial Database for sintilimab+bevacizumab
Every month we try and update this database with for sintilimab+bevacizumab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Effect and Safety of Huaier Granules Combined With Targeted Drugs and Anti-PD-(L)1 Antibody Compared With Targeted Drugs Combined With Anti-PD-(L)1 Antibody in First Line Treatment of Unresectable Hepatocellular Carcinoma(uHCC) | NCT05660213 | Unresectable He... | Huaier granule Atezolizumab + ... Camrelizumab+Ap... Sintilimab+Beva... | 18 Years - | Fudan University |